US-based medical device company Theragenics is set to open a manufacturing facility in San Jose, Costa Rica.

The facility, which has been taken on a lease basis, will manufacture components that are used in the vascular access product line.

Theragenics’ wholly-owned subsidiary Theragenics Costa Rica will operate the 17,200ft² facility, which is expected to commence operations by the end of this year.

This move of the company will create around 50 new jobs at the facility, which is slated to begin in the coming months.

Theragenics CEO Frank Tarallo said the opening of new facility in Costa Rica expands the firm’s footprint and manufacturing capabilities.

"This will allow us to be closer to our vascular access customers. Costa Rica is a country that understands and supports the medical device industry, and our facility there will deliver the same quality, dedication and service that have been our foundation for years," Tarallo added.

The company has two business segments, surgical products business and brachytherapy seed business. It produces wound closure products such as sutures and needles, as well as vascular products like introducers and guidewires.